FDA to evaluate regulatory framework for homeopathic products

The Food and Drug Administration (FDA) in the United States has announced an evaluation of the regulation of homeopathic products.

It will hold a public hearing in April to obtain information on the current use of both prescription and over-the-counter products labelled as homeopathic, and on the Agency’s regulatory framework for such products. FDA is seeking comments and information from all interested parties, including consumers, patients, caregivers, health care professionals, patient groups, and industry.

ECHAMP encourages its members to submit relevant information to this review of regulations, first issued in 1988 and last revised in 1995.